Genome-wide association study of the modified stumvoll insulin sensitivity index identifies BCL2 and FAM19A2 as novel insulin sensitivity loci

Diabetes

Volumn 65, Issue 10, 2016, Pages 3200-3211

  Walford, Geoffrey A ^a,b   Gustafsson, Stefan ^c   Rybin, Denis ^d   Stancáková, Alena ^e   Chen, Han ^d,f   Liu, Ching Ti ^d   Hong, Jaeyoung ^d   Jensen, Richard A ^g,h   Rice, Ken ^h   Morris, Andrew P ^i,j   Mägi, Reedik ^k   Tönjes, Anke ^l   Prokopenko, Inga ^j,m,n   Kleber, Marcus E ^o   Delgado, Graciela ^o   Silbernagel, Günther ^p   Jackson, Anne U ^q   Appel, Emil V ^r   Grarup, Niels ^r   Lewis, Joshua P ^s   Montasser, May E ^s   Landenvall, Claes ^c,t   Staiger, Harald ^u,v,w   Luan, Jian'An ^x   Frayling, Timothy M ^y   Weedon, Michael N ^y   Xie, Weijia ^y   Morcillo, Sonsoles ^z,aa   Martínez Larrad, María Teresa ^ab   Biggs, Mary L ^g,h   Chen, Yii Der Ida ^ac   Corbaton Anchuelo, Arturo ^ab   Færch, Kristine ^ad   Gómez Zumaquero, Juan Miguel ^aa,ae   Goodarzi, Mark O ^af   Kizer, Jorge R ^ag   Koistinen, Heikki A ^ah,ai,aj   Leong, Aaron ^a,b   Lind, Lars ^c   Lindgren, Cecilia ^j,ak   Machicao, Fausto ^v,w   Manning, Alisa K ^a,b,ak   Martín Núñez, Gracia María ^al   Rojo Martínez, Gemma ^aa,ae,am   Rotter, Jerome I ^ac   Siscovick, David S ^g,h,an   Zmuda, Joseph M ^ao   Zhang, Zhongyang ^ap   Serrano Rios, Manuel ^ab   Smith, Ulf ^aq   Soriguer, Federico ^aa,ae,am   Hansen, Torben ^r   JØrgensen, Torben J ^ar,as,at   Linnenberg, Allan ^ar,at,au   Pedersen, Oluf ^r   Walker, Mark ^av   Langenberg, Claudia ^x   Scott, Robert A ^x   Wareham, Nicholas J ^x   Fritsche, Andreas ^u,v,w   Häring, Hans Ulrich ^u,v,w   Stefan, Norbert ^u,v,w   Groop, Leif ^t,aj   O'Connell, Jeff R ^s   Boehnke, Michael ^q   Bergman, Richard N ^af   Collins, Francis S ^aw   Mohlke, Karen L ^ax   Tuomilehto, Jaakko ^ah,ay,az,ba   März, Winfried ^o,p,bb   Kovacs, Peter ^l   Stumvoll, Michael ^l   Psaty, Bruce M ^g,h,bc,bd   Kuusisto, Johanna ^e   Laakso, Markku ^e   Meigs, James B ^a,b,ak   Dupuis, Josée ^d,be   Ingelsson, Erik ^c,bf   Florez, Jose C ^a,b   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UPPSALA UNIVERSITY   (Sweden)

^d BOSTON UNIVERSITY   (United States)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ UNIVERSITY OF LIVERPOOL   (United Kingdom)

^j UNIVERSITY OF OXFORD   (United Kingdom)

^k UNIVERSITY OF TARTU   (Estonia)

^l UNIVERSITY OF LEIPZIG   (Germany)

^m IMPERIAL COLLEGE LONDON   (United Kingdom)

ⁿ UNIVERSITY OF OXFORD   (United Kingdom)

^o UNIVERSITY OF HEIDELBERG   (Germany)

^p MEDICAL UNIVERSITY OF GRAZ   (Austria)

^q UNIVERSITY OF MICHIGAN   (United States)

^r Capital Region   (Denmark)

^s UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^t LUND UNIVERSITY DIABETES CENTRE   (Sweden)

^u UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^v GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^w UNIVERSITY OF TÜBINGEN   (Germany)

^x UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^y UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^z Instituto de Salud Carlos III   (Spain)

^aa HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^ab HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^ac HARBOR UCLA MEDICAL CENTER   (United States)

^ad STENO DIABETES CENTER   (Denmark)

^ae Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina IBIMA Plataforma Bionand   (Spain)

^af CEDARS SINAI MEDICAL CENTER   (United States)

^ag ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^ah NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^ai MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

^aj UNIVERSITY OF HELSINKI   (Finland)

^ak HARVARD UNIVERSITY   (United States)

^al H Virgen de la Victoria   (Spain)

^am INSTITUTO DE SALUD CARLOS III   (Spain)

^an NEW YORK ACADEMY OF MEDICINE   (United States)

^ao UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^ap MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^aq UNIVERSITY OF GOTHENBURG   (Sweden)

^ar UNIVERSITY OF COPENHAGEN   (Denmark)

^as AALBORG UNIVERSITY   (Denmark)

^at Research Center for Prevention and Health   (Denmark)

^au Rigshospitalet   (Denmark)

^av NEWCASTLE UNIVERSITY   (United Kingdom)

^aw NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^ax UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^ay DANUBE UNIVERSITY KREMS   (Austria)

^az KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^ba DASMAN DIABETES INSTITUTE   (Kuwait)

^bb SYNLAB ACADEMY   (Germany)

^bc GROUP HEALTH RESEARCH INSTITUTE   (United States)

^bd Group Health   (United States)

^be NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^bf STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FAM19A2 PROTEIN; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; PEPTIDES AND PROTEINS; PROTEIN BCL 2; UNCLASSIFIED DRUG; BETA CHEMOKINE; FAM19A2 PROTEIN, HUMAN; INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, HUMAN;

ADULT; ARTICLE; ASSESSMENT OF HUMANS; BODY MASS; DIET RESTRICTION; FEMALE; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMAN; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STUMVOLL INSULIN SENSITIVITY INDEX; GENETIC PREDISPOSITION; GENETICS; INSULIN RESISTANCE; META ANALYSIS; PHYSIOLOGY; PROCEDURES; SINGLE NUCLEOTIDE POLYMORPHISM;

CHEMOKINES, CC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84989162879     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db16-0199     Document Type: Article

References (25)

1. Morris AP, Voight BF, Teslovich TM, et al.; Wellcome Trust Case Control Consortium; Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC) Investigators; Genetic Investigation of ANthropometric Traits (GIANT) Consortium; Asian Genetic Epidemiology Network-Type 2 Diabetes (AGEN-T2D) Consortium; South Asian Type 2 Diabetes (SAT2D) Consortium; DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 2012;44:981-990
2. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003;46: 3-19
3. Dimas AS, Lagou V, Barker A, et al.; MAGIC Investigators. Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes 2014;63:2158-2171
4. Bergman RN, Zaccaro DJ, Watanabe RM, et al. Minimal model-based insulin sensitivity has greater heritability and a different genetic basis than homeostasis model assessment or fasting insulin. Diabetes 2003;52:2168-2174
5. Rasmussen-Torvik LJ, Pankow JS, Jacobs DR, et al. Heritability and genetic correlations of insulin sensitivity measured by the euglycaemic clamp. Diabet Med 2007;24:1286-1289
6. Ingelsson E, Langenberg C, Hivert MF, et al.; MAGIC investigators. Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes 2010;59:1266-1275
7. Knowles JW, Xie W, Zhang Z, et al.; RISC (Relationship between Insulin Sensitivity and Cardiovascular Disease) Consortium; EUGENE2 (European Network on Functional Genomics of Type 2 Diabetes) Study; GUARDIAN (Genetics UndeRlying DIAbetes in HispaNics) Consortium; SAPPHIRe (Stanford Asian and Pacific Program for Hypertension and Insulin Resistance) Study. Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene [published correction appears in J Clin Invest 2016;126:403]. J Clin Invest 2015;125:1739-1751
8. Stumvoll M, Mitrakou A, Pimenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000;23:295-301
9. Stumvoll M, Van Haeften T, Fritsche A, Gerich J. Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 2001;24:796-797
10. Manning AK, Hivert M-F, Scott RA, et al.; DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium; Multiple Tissue Human Expression Resource (MUTHER) Consortium. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet 2012;44:659-669
11. Manning AK, LaValley M, Liu CT, et al. Meta-analysis of gene-environment interaction: Joint estimation of SNP and SNP 3 environment regression coefficients. Genet Epidemiol 2011;35:11-18
12. Scott RA, Lagou V, Welch RP, et al.; DIAbetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet 2012;44:991-1005
13. Knowles JW, Assimes TL, Tsao PS, et al. Measurement of insulin-mediated glucose uptake: Direct comparison of the modified insulin suppression test and the euglycemic, hyperinsulinemic clamp. Metabolism 2013;62:548-553
14. Yang J, Ferreira T, Morris AP, et al.; Genetic Investigation of Anthropometric Traits (GIANT) Consortium; DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat Genet 2012;44:369-375, S1-3
15. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998;62:1198-1211
16. Otten J, Ahrén B, Olsson T. Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: A meta-analysis. Diabetologia 2014;57: 1781-1788
17. Kashyap SR, Belfort R, Berria R, et al. Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes. Am J Physiol Endocrinol Metab 2004;287:E537-E546
18. Perseghin G, Ghosh S, Gerow K, Shulman GI. Metabolic defects in lean nondiabetic offspring of NIDDM parents: A cross-sectional study. Diabetes 1997; 46:1001-1009
19. Vaag A, Henriksen JE, Beck-Nielsen H. Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1992;89:782-788
20. Saxena R, Elbers CC, Guo Y, et al.; Look AHEAD Research Group; DIAGRAM consortium. Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci [published correction appears in Am J Hum Genet 2012;90: 753]. Am J Hum Genet 2012;90:410-425
21. Shungin D, Winkler TW, Croteau-Chonka DC, et al.; ADIPOGen Consortium; CARDIOGRAMplusC4D Consortium; CKDGen Consortium; GEFOS Consortium; GENIE Consortium; GLGC; ICBP; International Endogene Consortium; LifeLines Cohort Study; MAGIC Investigators; MuTHER Consortium; PAGE Consortium; ReproGen Consortium. New genetic loci link adipose and insulin biology to body fat distribution. Nature 2015;518:187-196
22. Brenner D, Mak TW. Mitochondrial cell death effectors. Curr Opin Cell Biol 2009;21:871-877
23. Luciani DS, White SA, Widenmaier SB, et al. Bcl-2 and Bcl-xL suppress glucose signaling in pancreatic b-cells. Diabetes 2013;62:170-182
24. Roberts AW, Davids MS, Pagel JM, et al. Targeting BCL2 with Venetoclax in relapsed chronic lymphocytic leukemia. N Engl J Med 2016;374:311-322
25. Stancáková A, Javorsk M, Kuulasmaa T, Haffner SM, Kuusisto J, Laakso M. Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes 2009;58:1212-1221